Published in
Elsevier, Clinical Genitourinary Cancer, 4(18), p. 314-321.e1, 2020
DOI: 10.1016/j.clgc.2019.11.010
Links
Tools
A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality
Journal article published in 2020 by
Carlotta Palumbo 
,
Elio Mazzone ,
Francesco A. Mistretta,
Sophie Knipper ,
Paul Perrotte,
Shahrokh F. Shariat,
Fred Saad,
Anil Kapoor ,
Jean-Baptiste Lattouf,
Claudio Simeone,
Alberto Briganti,
Alessandro Antonelli,
Pierre I. Karakiewicz
,
Elio Mazzone ,
Francesco A. Mistretta,
Sophie Knipper ,
Paul Perrotte,
Shahrokh F. Shariat,
Fred Saad,
Anil Kapoor ,
Jean-Baptiste Lattouf,
Claudio Simeone,
Alberto Briganti,
Alessandro Antonelli,
Pierre I. Karakiewicz
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 